Blog Archives

PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF]  05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The study is being funded by a $1,743,051 Phase II Small

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies’ Kinesia Technology Receives TGA Approval for Parkinson’s Assessment in Australia

VIEW PRESS RELEASE [PDF] 9 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line [ http://glneurotech.com/kinesia/ ] includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor, bradykinesia, and dyskinesia associated

Read more ›


PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine

VIEW PRESS RELEASE [PDF] 13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress in Dublin, Ireland.  The Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/  ] system

Read more ›


PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of motor symptoms associated with movement disorders.  These intellectual property claims

Read more ›


PRESS RELEASE: GLNT Begins Clinical Study to Demonstrate High Sensitivity Motor Symptom Detection in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] March 23, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have begun a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with Parkinson’s disease (PD). The study, funded by the National Institutes

Read more ›


PRESS RELEASE: GLNT Awarded Patent for Technology to Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 8MAR2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have received allowance of claims from the U.S. Patent Office for an application covering their Movement Disorder Monitoring System and Method for quantitative assessment of motor symptoms associated with movement disorders. The claims cover

Read more ›


PRESS RELEASE: CLEVEMED ASSISTS AMERICAN MEDICAL ASSOCIATION IN RELEASE OF CPT CODE FOR RECORDING PHYSIOLOGIC TREMOR

VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO (April 25, 2009) – The American Medical Association (AMA) CPT® Editorial Panel approved the release of Category III CPT code 0199T for physiologic recording of tremor using accelerometer(s) and gyroscope(s), (including frequency and amplitude) including interpretation and report. Cleveland Medical Devices Inc. (CleveMed) has

Read more ›


PRESS RELEASE: CLEVEMED RECEIVES $1.23 MILLION IN NIH FUNDING TO DEVELOP A SYSTEM TO AUGMENT DEEP BRAIN STIMULATION PROGRAMMING IN PARKINSON´S DISEASE

VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO, OCT 7, 2008 – Cleveland Medical Devices Inc. (CleveMed) announced it has been awarded $1.23 million in NIH SBIR FastTrack funding from the National Institute on Aging to develop ParkinTune™, a system to augment stimulator programming in deep brain stimulation (DBS) procedures for Parkinson´s

Read more ›